BREATHTEK

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 05,health professional report with the FDA on 2012-06-11 for BREATHTEK manufactured by Otsuka Pharmaceutical.

Event Text Entries

[16729651] Bronchospasm [bronchospasm]. Difficulty breathing [difficulty breathing]. Case description: this physician reported that a patient of unknown age and gender drank one pouch of pranactin-citric solution for the purpose of preparing for the breathtek test. The patient's relevant medical history, concomitant medications and relevant past drug history are unknown. On (b)(6) 2011, the patient experienced difficulty breathing 5 to 7 minutes after drinking the pranactin-citric solution. On (b)(6) 2011, the physician states the patient's difficulty breathing is better. It is unknown if there is any relevant laboratory data. As of (b)(6) 2011, it is unknown if the patient continues to use the pranactin-citric solution and the physician reported that the patient's difficulty breathing is better. The reporting physician requested a call back to gather further information for safety report. An outbound call was placed at 1002 on (b)(6) 2011 and a voicemail message was reached. Physician unavailable. Limited information available. Follow up information received on may 17, 2012: patient's credentials (initials, age and gender), medical history, suspect product details and concomitant medication were provided. The patient's medical history included reactive airway disease and hypertension. Concomitant medication included atacand for an unknown indication. On (b)(6) 2011, the patient received pranactin citric solution at a dose of 3 mg by mouth for abdominal pain and suspected h. Pylori. On (b)(6) 2011, the physician reported that bronchospasms began when the patient breathed into the collection bag to provide a breath sample. The patient was administered a bronchodilator and the bronchospasm improved upon observation. No relevant laboratory testing was performed. At the time of this report, treatment with pranactic citric solution was stopped and bronchospasm had resolved. The reporter did not confirm whether bronchospasm was due to pranactin citric solution or the coating inside the bag.
Patient Sequence No: 1, Text Type: D, B5


[17045047] Reporter's causality assessment: the reporter did not provide the causality. Otsuka's causality assessment: otsuka assessed the event as related to pranactin citric.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number3000718406-2012-00002
MDR Report Key2621330
Report Source05,HEALTH PROFESSIONAL
Date Received2012-06-11
Date of Report2017-11-01
Date of Event2011-08-24
Date Mfgr Received2017-09-14
Date Added to Maude2012-08-06
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactDR MIRZA RAHMAN
Manufacturer Street508 CARNEGIE CENTER DRIVE SUITE 500
Manufacturer CityPRINCETON NJ 08540
Manufacturer CountryUS
Manufacturer Postal08540
Manufacturer G1OTSUKA AMERICA PHARMACEUTICAL INC.
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameBREATHTEK
Generic NameUREA BREATH TEST (UBT) AND CALCULATION SOFTWARE
Product CodeMSQ
Date Received2012-06-11
OperatorLAY USER/PATIENT
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerOTSUKA PHARMACEUTICAL
Manufacturer Address508 CARNEGIE CENTER PRINCETON NJ 08540 US 08540


Patients

Patient NumberTreatmentOutcomeDate
101. Other; 2. Required No Informationntervention 2012-06-11

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.